Guia de Reabilitação na Síndrome de Guillain-Barré

O que podemos fazer?

Autores

  • Marco Orsini Undergratuated in Medicine – Universidade do Grande Rio and Underdoctored in Neurosciences, Federal Fluminense University – UFF, NiteróiRJ, Chair of Neurological Rehabilitation – ESEHA, Niterói-RJ, Brazil
  • Marcos RG de Freitas Neurologist, Chair of Neurology and Chief of Staff, Neurology Department, Federal Fluminense University – UFF, Niterói-RJ, Brazil
  • Bruno Presto Physical Therapist, Neuroscience’s Department, Federal Fluminense University – UFF, Niterói-RJ, Brazil
  • Mariana P Mello Physical Therapist, Neuroscience’s Department, Federal Fluminense University – UFF, Niterói-RJ, Brazil
  • Carlos Henrique Melo Reis Neurologist, Neurology Department, Universidade Iguaçu – UNIG, Valença University of Medicine, Nova Iguaçu-RJ, Brazil
  • Valéria Silveira Neurologist, Neurology Department, Universidade Iguaçu – UNIG, Valença University of Medicine, Nova Iguaçu-RJ, Brazil
  • Júlio Guilherme Silva Physical Therapist, Anatomy Department – UFF, Rio de JaneiroRJ, Brazil
  • Osvaldo JM Nascimento Neurologist, Chair of Neurology, Neurology Department, Federal Fluminense University – UFF, Niterói-RJ, Brazil
  • Marco Antônio Araújo Leite Neurologist, Neurology Service, Federal Fluminense University – UFF, Niterói-RJ, Brazil
  • Soraia Pulier Neurologist, Quinta Dor Hospital, Neurology Service – UFF, Niterói-RJ, Brazil
  • Marzia Puccioni Sohler Neurologist, Neurology Department, Federal University of the State of Rio de Janeiro – UNIRIO, Rio de Janeiro-RJ, Brazil.

DOI:

https://doi.org/10.34024/rnc.2010.v18.8443

Palavras-chave:

Síndrome de Guillain-Barré, Reabilitação, Fisioterapia

Resumo

Introdução. Originalmente descrita por Landry em 1859 e Guillain, Barre e Strohl em 1916, a Síndrome de Guillain-Barré (SGB) é a causa mais comum de paralisia neuromuscular aguda autolimitada em países desenvolvidos. A incidência anual varia de 1.5casos|100.000. Embora possua prognóstico favorável, sua taxa de mortalidade encontra-se entre 5% e 10% dos pacientes que permanecem gravemente incapacitados até 1 ano após os primeiros sintomas. Profissionais especializados, tratamento intensivo e reabilitativo são essenciais para o gerenciamento dessa clientela. Objetivo. Nortear profissionais da saúde sobre a utilização de técnicas fisioterapêuticas (motora e respiratória) em pacientes com SGB, assim como o momento correto de sua utilização. Método. Atualização sobre artigos envolvendo SGB e reabilitação, nos últimos anos nas bases de dados Bireme, ScienceDirect, PubMed e Scielo. Conclusão. Não existe na atualidade um consenso sobre o gerenciamento de pacientes com SGB nos estágios agudo, sub-agudo e crônico. Infelizmente muitos pacientes recebem alta hospitalar sem informação e acesso aos serviços de reabilitação. Nossos resultados sugerem que a reabilitação (motora e respiratória) promove diferenças significativas na restauração funcional desses pacientes.

Métricas

Carregando Métricas ...

Downloads

Não há dados estatísticos.

Referências

Créange A, Sharshar T, Raphaël JC, Gherardi R. Cellular aspect of neuroinflammation in Guillain-Barré syndrome: a key to a new therapeutic option? Rev Neurol (Paris) 2002;158:15-27.

Baravelli M, Rossi A, Picozzi A. A case of Guillain-Barré syndrome following Staphylococcus aureus endocarditis. Int J Cardiol 2007;114:E53-5.

Dhar R, Stitt L, Hahn AF. The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit. J Neurol Sci 2008;264:121-8.

Gregory MA, Gregory RJ, Podd JV. Understanding Guillain-Barré syndrome and central nervous system involvement. Rehabil Nurs 2005;30:207-12.

Haldeman D, Zulkosky K. Treatment and nursing care for a patient with Guillain-Barré syndrome. Dimens Crit Care Nurs 2005;24:267-72.

Hughes RA, Wijdicks EF, Benson E. Supportive care for patients with Guillain-Barré syndrome. Arch Neurol 2005; 62:1194-8.

Winer JB. Guillain Barré syndrome. J Clin Pathol: Mol Pathol 2001;54:381-5.

Forsberg A, Press R, Einarsson U. Disability and health-related quality of life in Guillain-Barré syndrome during the first two years after onset: a prospective study. Clin Rehabil 2005;19:900-9.

Conomy JP, Braatz JH. Guillain-Barré syndrome: the physical therapist and patient care. Phys Ther 1971;51:517-23.

Garssen MJP, Koningsveld RV, Van Doorn PA. Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome. J Neurol 2006;253:1143-6.

Dornonville de la Cour C, Andersen H, Stalberg E, Fuglsang-Frederiksen A, Jakobsen J. Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barré syndrome. Muscle Nerve 2005;31:70-7.

Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994;18(Suppl 1):S79-S83.

Garssen MPJ, Schillings ML, Van Doorn PA, Van Engelen BG, Zwarts MJ. Contribution of central and peripheral factors to residual fatigue in guillain-barré syndrome. Muscle Nerve 2007;36:93-9.

Hallum A. Neuromuscular diseases. In: Umphred DA. Neurological Rehabilitation. 4th ed. St Louis: Mosby, 2001, p.363-415.

Meythaler JM. Rehabilitation of Guillain Barre syndrome. Arch PhysMed Rehabil 1997;78:872-9.

Winer JB, Hughes RAC, Greenwood RJ, Perkin GD, Healy MJ. Prognosis in Guillain Barré syndrome. Lancet 1985; 1:1202–3.

Karavatas SG. The role of neurodevelopmental sequencing in the physical therapy management of a geriatric patient with Guillain-Barré syndrome. Topics Geriatric Rehab 2005;21:133-5.

Tuckey J, Greenwood R. Rehabilitation after severe Guillain-Barré syndrome: the use of partial body weight support. Physiother Res Inter 2004;9:96-103.

Bulley P. The podiatron: an adjunct to physiotherapy treatment for Guillain-Barré syndrome? Physiotherapy Research International 2003;8:210-5.

Taylor S. The ventilated patient undergoing hydrotherapy: a case study. Aus Crit Care 2003;16:111-5.

Orsini M, De Freitas MRG, Nascimento OJM. Effectiveness of an Individualized program, based on proprioceptive neuromuscular facilitation techniques in a patient with inclusion body myositis with HIV infection: Description and Preliminary Results. Supplement to Neurology I, 2008; 70 (11): A146.

Ruhland JL, Shields RK. The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther 1997;77:1026-39.

Garssen MPJ, Bussmann JBJ, Schmitz PIM, Zandbergen A, Welter TG, Merkies IS, et al. Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP. Neurology 2004;63:2393-5.

Latov N, Wokke JHJ, Kelly JJ. Immunological and Infections Diseases of the Peripheral Nerves. Part V, Chapter 27, Cambridge University Press, 1998, p.435.

Michaelis J. Mechanical methods of controlling ataxia. Baillieres Clin Neurol 1993;2:121-39.

Broadhurst MJ, Stammers CW. Mechanical feeding aids for people with ataxia: design considerations. J Biomed Eng 1990;12:209-14.

Graham C, Laskow-McCarthey P. Exercise options for persons with diabetic complication. Diabetes Educ 2000; 16:212-20.

Fishbain DA, Chabal C, Abbot A, Heine LW, Cutler R. Transcutaneous electrical nerve stimulation (TENS): Treatment outcome in long-term users. Clin J Pain1996;12:201-14.

Hay-Smith EJ, Bo K, Berghmans LC. Pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev 2006;(1), CD001407.

William B, Karper ED. Effects of low-intensity aerobic exercise on one subject with Chronic Relapsing Guillain-Barré Syndrome. Rehab Nurse 1991;16:96-8.

Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996;39:432-41.32.Ruhland JL, Shields RK. The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther 1997;77:1026-39.

Hennessey WJ, Johnson EW. Lower limb orthoses. In: Braddom, RL (ed): Physical Medicine and Rehabilitation. Ed 2. Philadelphia, Saunders, 2000, p 326-52.

Hill NS. Neuromuscular disease in respiratory and critical care medicine. Respiratory Care 2006;51:1065-71.

Aggarwal AN, Gupta D, Lal V, Behera D, Jindal SK, Prabhakar S. Management of Respiratory Failure in Patients with Severe Guillain-Barré Syndrome. Neurology India 2003;51:203-5.

Ali MI, Fernandez-Perez ER, Pendem S, Brown DR, Wijdicks EF, Gajic O. Mechanical Ventilation in Patients With Guillain-Barré Syndrome. Respir Care 2006;51:1403–7.

Mehta S. Neuromuscular Disease Causing Acute Respiratory Failure. Respir Care 2006;51:1016–21.

Nguyen TN, Badjatia N, Malhotra A, Gibbons FK, Qureshi MM, Greenberg SA. Factors Predicting Extubation Success in Patients with Guillain-Barré Syndrome. Neurocrit Care 2006;5:230–4.

Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating Mechanical Ventilation in Guillain-Barré Syndrome. Arch Neurol 2001;58:893-8.

Berger AR, Schaumberg HH. Rehabilitation of peripheral neuropathies. J Neurol Rehab, 1988;2:25-36.

Hughes RAC, Wijdicks E, Barohn RJ, Benson E, Cornblath DR, Hahn AF, et al. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurol 2003;61:736-40.

Prevots DR, Sutter RW. Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. J Infect Dis 1997;175(suppl 1):S151-5.

Raphael JC, Masson C, Morice V, Bronel D, Goulon M. Le syndrome de Guillain Barré: étude retrospective de 233 observations. Sem Hop Paris 1984;60:2543- 6.

Rees JH, Thompson RD, Smeeton NC, Hughes RAC. An epidemiological study of Guillain-Barré syndrome in South East England. J Neurol Neurosurg Psychiatry 1998;64:74-7.

GBS Support Group. Guillain-Barré Syndrome Support Group (Internet Address). England. (update: 01/2008, accessed in: 06/2008). Available at: www.gbs.org.uk

Pitetti KH, Barrett PJ, Abbas D. Endurance exercise training in Guillain-Barré syndrome. Arch Phys Med Rehab 1993;74:761-5.

Meythaler JM, Korkor AB, Nanda T, Kumar NA, Fallon M. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome: successful therapy with combined calcitonin and etidronate. Arch Intern Med 1986;146:1567-71.

Downloads

Publicado

2010-12-31

Como Citar

Orsini, M., de Freitas, M. R., Presto, B., Mello, M. P., Reis, C. H. M., Silveira, V., … Sohler, M. P. (2010). Guia de Reabilitação na Síndrome de Guillain-Barré: O que podemos fazer?. Revista Neurociências, 18(4), 572–580. https://doi.org/10.34024/rnc.2010.v18.8443

Edição

Seção

Atualização

Artigos Semelhantes

1 2 3 4 5 6 7 8 9 10 > >> 

Você também pode iniciar uma pesquisa avançada por similaridade para este artigo.

Artigos mais lidos pelo mesmo(s) autor(es)

1 2 3 4 5 6 > >>